Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Bloomer

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Head & Neck|March 1, 1989
Effect of prior radiotherapy on postsurgical wound infectionJ T Johnson, W D Bloomer
Nuclear Medicine and Biology|July 1, 1995
Solid phase labeling of monoclonal antibodies with 99mTc using two bifunctional photocleavable reagentsG N Ranadive, W D Bloomer
International Journal of Nuclear Medicine and Biology|January 1, 1981
Iodine-125 cytotoxicity: implications for therapy and estimation of radiation riskW D Bloomer, S J Adelstein
The British Journal of Radiology|September 1, 1979
Mediastinal lymphoscintigraphy reflects cell kinetics of developing malignant ascitesW D Bloomer, S J Adelstein
Nature|February 17, 1977
5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emittersW D Bloomer, S J Adelstein
Surgery, Gynecology & Obstetrics|August 1, 1980
Tolerance of the intestine to radiation therapyT J Kinsella, W D Bloomer
Lancet (London, England)|August 10, 1985
Abnormally diminished sense of smell in women with oestrogen receptor positive breast cancerS Lehrer, E Levine, W D Bloomer
In Vivo (Athens, Greece)|January 1, 1996
THNLA-1: a DNA-targeted bioreductive agent as chemosensitizer in vitro and in vivoM V Papadopoulou, M Ji, W D Bloomer
Cancer Chemotherapy and Pharmacology|January 1, 1992
Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenolJ A Prezioso, N Wang, W D Bloomer
Cancer|May 1, 1985
Antibody-mediated radiotherapyW D Bloomer, R Lipsztein, J F Dalton
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Head & Neck|March 1, 1989
Effect of prior radiotherapy on postsurgical wound infectionJ T Johnson, W D Bloomer
Nuclear Medicine and Biology|July 1, 1995
Solid phase labeling of monoclonal antibodies with 99mTc using two bifunctional photocleavable reagentsG N Ranadive, W D Bloomer
International Journal of Nuclear Medicine and Biology|January 1, 1981
Iodine-125 cytotoxicity: implications for therapy and estimation of radiation riskW D Bloomer, S J Adelstein
The British Journal of Radiology|September 1, 1979
Mediastinal lymphoscintigraphy reflects cell kinetics of developing malignant ascitesW D Bloomer, S J Adelstein
Nature|February 17, 1977
5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emittersW D Bloomer, S J Adelstein
Surgery, Gynecology & Obstetrics|August 1, 1980
Tolerance of the intestine to radiation therapyT J Kinsella, W D Bloomer
Lancet (London, England)|August 10, 1985
Abnormally diminished sense of smell in women with oestrogen receptor positive breast cancerS Lehrer, E Levine, W D Bloomer
In Vivo (Athens, Greece)|January 1, 1996
THNLA-1: a DNA-targeted bioreductive agent as chemosensitizer in vitro and in vivoM V Papadopoulou, M Ji, W D Bloomer
Cancer Chemotherapy and Pharmacology|January 1, 1992
Thymidylate synthase as a target enzyme for the melanoma-specific toxicity of 4-S-cysteaminylphenol and N-acetyl-4-S-cysteaminylphenolJ A Prezioso, N Wang, W D Bloomer
Cancer|May 1, 1985
Antibody-mediated radiotherapyW D Bloomer, R Lipsztein, J F Dalton
Pageof 11